JUSTIN IORIO, M.D.

Plain English
This study looked at how childhood sexual and family violence affects adult victimization in women who are homeless in Buenos Aires, Argentina. Researchers interviewed 72 women and found that those who experienced violence as children were more likely to face further trauma in adulthood, which can keep them homeless. This matters because addressing these early traumatic experiences can help create better support systems and public policies to reduce ongoing victimization and social exclusion. Who this helps: This helps women experiencing homelessness and those who support them, including social workers and policymakers.

Plain English
This study focuses on finding recurring patterns, called functional motifs, in data that can change over time, like temperature or food prices. The researchers developed a new method called funBIalign that uses a multi-step approach to identify these patterns. They found this method outperforms other techniques in recognizing motifs and successfully applied it to real-world data, demonstrating its effectiveness. Who this helps: This helps researchers and analysts studying trends in time-sensitive data.

Plain English
This study looked at how women experiencing homelessness in Buenos Aires, Argentina, feel they are treated unfairly and face discrimination. Out of 72 women interviewed, most reported experiencing discrimination, with over two-thirds fearing insults or being detained without reason, primarily due to their homelessness, gender, and poverty. This research highlights the unique challenges these women face and can inform better policies and programs to support them. Who this helps: This helps women experiencing homelessness and organizations working to support them.

Plain English
This study examined a group of proteins that form a complex in human breast cancer cells, specifically looking at how they influence cancer behavior and patient outcomes. Researchers found that high levels of certain proteins (hERG1 and nNav1.5) within this complex are linked to worse survival rates in patients, indicating that the complex could help identify those at higher risk. This finding is important as it suggests the complex could serve as a new biomarker and a potential target for treatment in breast cancer patients. Who this helps: Patients with breast cancer.

Plain English
This research studied a specific protein complex in pancreatic cancer cells and how it affects cancer growth and movement. The study found that disrupting this complex, either by using a specific antibody or by using statins (common cholesterol-lowering drugs), significantly reduced cell growth and movement. In mouse models, combining statins with this antibody not only slowed tumor growth but also improved survival rates. Who this helps: This benefits pancreatic cancer patients by potentially providing a new treatment strategy.

Plain English
This study explored a new type of cancer treatment designed to kill cancer cells by triggering their death mechanisms. Researchers developed a specialized antibody that targets specific cancer markers and combines this with a molecule that promotes cell death, showing that it significantly reduced tumor growth in lab and animal studies. Specifically, it was effective against triple-negative breast cancer, a hard-to-treat form, suggesting it could be a promising new option for patients facing this challenge. Who this helps: This helps patients with hard-to-treat types of cancer, especially those with triple-negative breast cancer.

Plain English
This study looked at how specific proteins called K channels, particularly one known as hERG1, are involved in the growth of certain blood cancers called diffuse large B cell lymphomas (DLBCL). Researchers found that hERG1 works with another protein, β1 integrin, to help lymphoma cells grow. When they disrupted this partnership, either with a special antibody or a common antibiotic called clarithromycin, they saw a significant decrease in cancer cell growth and noted that patients with a specific form of lymphoma had better survival rates when treated with this antibiotic. Who this helps: This research benefits patients with B cell lymphomas and their doctors by offering potential new treatment options.

Plain English
This study looked at how eating different types of fats, specifically omega-3 and omega-6 fatty acids, affects the amount of fat around the organs in the body, known as visceral fat, in 697 adults from Brazil. The researchers found that higher intakes of omega-3 fats (like EPA and DHA) were linked to lower levels of visceral fat in women, while omega-6 fats were associated with higher visceral fat levels in women but had a different effect on men. Understanding these relationships is important because it can guide dietary recommendations for reducing fat-related health risks, particularly for women. Who this helps: This helps patients and healthcare providers looking to improve dietary habits and manage obesity-related health risks.

Plain English
This study looked at death rates during two early COVID-19 waves in Italy, analyzing data from all 107 provinces. Researchers found that the first wave had higher death rates that peaked sharply, while the second wave spread out over a longer period with lower peaks. They also discovered that restricting movement and enforcing government rules significantly reduced deaths during both waves. Who this helps: This helps public health officials and policymakers make better decisions for managing future pandemics.

Plain English
Researchers studied how a specific potassium channel called hERG1 behaves in cancer cells when it interacts with proteins that help cells stick to their surroundings (integrins). They found that when a protein called fibronectin is present, hERG1 moves to the cell surface and avoids being broken down, which influences cancer cell movement and behavior. This process is important because it shows how cancer cells can adapt and move, potentially leading to their spread in the body. Who this helps: This research benefits doctors and researchers working on cancer treatments.

Plain English
The study looked at why some parents in seven European countries are hesitant to vaccinate their children, especially in the context of COVID-19. It found that factors such as social background and media coverage play significant roles in vaccine hesitancy. The research aims to help healthcare professionals better understand these issues and improve conversations about vaccines with parents, which is crucial for increasing vaccination rates and protecting children's health. Who this helps: This benefits parents and healthcare providers working to increase childhood vaccination rates.

Plain English
This study focused on finding new ways to treat certain aggressive cancers, specifically targeting a unique protein complex made up of hERG1 and another protein called β1 integrin. Researchers created a new kind of antibody (called scDb-hERG1-β1) that specifically targets this complex and showed promising results in laboratory tests. This approach could lead to safer cancer treatments that don't harm the heart, which is a common problem with other therapies targeting hERG1. Who this helps: This helps cancer patients, especially those with aggressive types like breast and pancreatic cancer.

Plain English
This study examined how media in seven European countries discussed vaccines during the Covid-19 pandemic, comparing the coverage before and after the outbreak. The findings showed that, while there were notable differences in public attitudes and perceptions of risk across countries, the urgency of the pandemic shaped a common discourse around vaccines and vaccine hesitancy. This matters because it highlights how societal factors influence people's willingness to get vaccinated and suggests that understanding these factors can help improve vaccine uptake in the future. Who this helps: This benefits public health officials, policymakers, and communities aiming to increase vaccination rates.

Plain English
This study focused on how a special fabric containing Germanium affects the growth of cartilage cells from fat-derived stem cells. Researchers found that after 21 days, the fabric increased important markers for cartilage development and improved the amount of cartilage-related materials, suggesting it helps with cartilage regeneration. This is important because osteoarthritis affects over 500 million people worldwide, and finding effective treatments could greatly improve their quality of life. Who this helps: This research benefits patients with osteoarthritis and healthcare providers looking for better treatment options.

Plain English
This research focuses on tiny particles called extracellular vesicles (EVs) that are released by cells and play a crucial role in communication within the body. The study shows that EVs can help diagnose diseases, support cancer treatments, and improve the success of organ transplants. Because they can deliver medications directly to specific cells, EVs could significantly improve how we treat various health conditions. Who this helps: This benefits patients with cancer, organ transplant recipients, and those suffering from neurological diseases.

Plain English
This research paper focuses on how to isolate and study extracellular vesicles (EVs), which are tiny packets released by cells that help communicate with other cells. The authors describe specific methods for extracting EVs from sources like blood and urine, which is important for understanding how these vesicles work in health and disease. Improving these techniques could lead to better ways to use EVs in medical tests and treatments. Who this helps: Patients and medical researchers.

Plain English
This research focused on a specific potassium channel called hERG1 and its behavior in tumors of the gastrointestinal tract. The study found that high levels of hERG1 in advanced cancers, like colorectal and pancreatic cancer, indicate a poor prognosis, while in neuroendocrine cancers of the ileum and pancreas, high hERG1 levels suggest better survival. Understanding how hERG1 interacts with other proteins could help identify risk factors in patients and how tumors grow and spread. Who this helps: This benefits patients with gastrointestinal tumors and their doctors by improving risk assessment and treatment options.

Plain English
This study focused on creating new compounds to fight leishmaniasis, a disease affecting over 350 million people without a vaccine and limited treatment options. Researchers developed 17 flavonoid derivatives that effectively inhibited enzymes linked to the disease, showing strong activity while being safe for human cells. These findings are significant because they pave the way for developing better treatments for leishmaniasis, aiming to meet global health goals. Who this helps: This helps patients suffering from leishmaniasis and healthcare providers looking for more effective treatments.

Plain English
This study looked at a new treatment for pancreatic cancer (PDAC) by combining a drug called Gemcitabine with a special antibody that targets a part of cancer cells called the hERG1/β1 integrin complex. The researchers found that this combination not only works better at shrinking tumors, even with lower doses of Gemcitabine (5 mg/kg), but also helps patients survive longer with fewer side effects compared to higher doses of the drug alone. This is important because it offers a way to treat a very aggressive type of cancer with less toxicity, improving quality of life for patients. Who this helps: Patients with pancreatic cancer.

Plain English
This study looked at a chemical process called olefin metathesis, which is used to convert certain building blocks into more useful chemicals in industries like plastics and fuels. Researchers discovered a new cycle in the process that helps renew the active sites in the catalysts, boosting the efficiency of producing propylene by up to 30 times at a temperature of 250°C. This finding is important because it can make the production of propylene more economical and less energy-intensive, potentially benefiting various chemical production methods. Who this helps: This helps chemical manufacturers and industries relying on efficient propylene production.

Plain English
This study looked at genetic mutations in the blood of patients with advanced colon cancer to see how well this method works compared to traditional tissue tests. They found that the blood test could detect mutations with an accuracy of 89.5%, and those with more aggressive tumors had higher mutation levels. This is important because it helps doctors spot disease progression earlier than standard imaging tests, potentially leading to quicker treatment adjustments for patients. Who this helps: This benefits metastatic colorectal cancer patients and their doctors.

Plain English
This study examines how stigma negatively affects health by looking at it as a widespread system rather than just individual experiences. The authors argue that powerful groups use stigma as a tool to maintain their control, and they present a framework that connects stigma to broader issues like race and gender inequality. Understanding this "stigma system" can help improve public health strategies by addressing the root causes of stigma instead of just its individual effects. Who this helps: This helps public health officials and advocates working to reduce stigma and improve health outcomes for marginalized groups.

Plain English
This study looked at a specific protein called hERG1 in tissue samples from patients with precancerous growths in the colon called colorectal adenomas. They found that hERG1 was present in 56.5% of the samples, with higher levels in more serious cases of dysplastic adenomas compared to less serious hyperplastic lesions. Understanding the levels of hERG1 could help doctors identify patients at greater risk of developing cancer, making early diagnosis and treatment more effective. Who this helps: This helps patients at risk for gastrointestinal cancers and their doctors.

Plain English
This study looked at a specific protein, called hERG1, in patients with neuroendocrine tumors (NETs) in the ileum (small intestine) and pancreas. The researchers found that higher levels of hERG1 were linked to longer survival for patients with ileal NETs and for those with aggressive, advanced-stage pancreatic NETs. However, increased hERG1 levels appeared to be associated with shorter survival for patients with less aggressive tumors. Who this helps: This research helps patients with neuroendocrine tumors and their doctors in understanding prognosis and treatment options.

Plain English
This study examined how a protein called hERG1 interacts with another protein, β1 integrin, and how this affects cell behavior in both normal kidney cells and cancer cells. Researchers found that when the kidney cells engineered to express hERG1 were placed on a specific environment (fibronectin), the electrical activity of hERG1 increased significantly. Similarly, neuroblastoma cancer cells showed improved hERG1 activity when placed on a different protein surface (laminin). This research highlights the importance of these protein interactions, suggesting they could be a target for new cancer treatments. Who this helps: This helps cancer patients by potentially leading to new therapies that target their tumors more effectively.

Plain English
This study looked at the metabolism of cancer stem cells in a type of liver cancer called cholangiocarcinoma. Researchers found that these cancer stem cells use their mitochondria, the cell's energy factories, more efficiently compared to other cancer cells, and high levels of a specific protein called PGC-1α were linked to worse patient outcomes, such as lower survival rates and faster tumor recurrence. This research is important because it suggests that targeting mitochondrial function could lead to new treatments for patients suffering from cholangiocarcinoma. Who this helps: This benefits patients with cholangiocarcinoma and their doctors by potentially offering new treatment options.

Plain English
This study focused on creating a new type of engineered antibody called a single-chain diabody (scDb) that targets a specific protein complex involved in cell signaling. Researchers successfully produced this diabody using a yeast called Pichia pastoris and compared two different methods for extracting the protein, finding both were effective. This research is important because it paves the way for producing useful proteins for therapies and diagnostics more efficiently. Who this helps: This benefits researchers and companies developing new medical treatments.

Plain English
This study looked at mice that were genetically modified to have high levels of a hormone receptor called LH-R in their reproductive systems. The researchers found that these mice developed tumor masses in their uteruses that were similar to endometrial cancer, especially as they got older. Notably, in human cases of early-stage endometrial cancer, there was also a connection to higher LH-R levels, suggesting that this hormone receptor may play a role in the development of this type of cancer. Who this helps: This research benefits patients at risk for endometrial cancer and doctors looking for better ways to understand and treat the disease.

Plain English
Researchers developed a new type of targeted treatment for solid cancers by creating a small antibody that can specifically attack a protein complex found in cancer cells, without affecting healthy cells. Their findings showed that this antibody successfully reduced tumor growth and blood vessel formation in models of colon and pancreatic cancers, with a safe dosage of up to 8 mg/kg. This work is important because it offers a promising new strategy for treating certain hard-to-treat cancers while sparing healthy tissues. Who this helps: This helps cancer patients, particularly those with colon or pancreatic cancer.

Plain English
This study looked at a protein called nNav1.5 in colorectal cancer (CRC) tissues to see how it relates to the disease’s severity and progression. The researchers found that nNav1.5 was present at significantly higher levels in cancer samples compared to normal tissue, especially in advanced stages of cancer where it was linked to worse patient outcomes, including shorter progression-free survival. Understanding nNav1.5's role may help doctors better categorize CRC patients and develop new treatments that target this protein. Who this helps: Patients with colorectal cancer and their doctors.

Plain English
This research paper looks at diseases like leishmaniasis and trypanosomiasis, which are major health issues in poorer regions of South America and Africa. The study highlights cysteine proteases—important enzymes for the survival of these parasites—as potential targets for new drug treatments. By focusing on these enzymes, researchers aim to find better and safer medications since current treatments often have serious side effects and face issues with drug resistance. Who this helps: This benefits patients suffering from leishmaniasis and trypanosomiasis.

Plain English
This study looked at how COVID-19 deaths varied across 20 regions in Italy and what factors influenced those trends, such as people's movement and the level of testing. Researchers found that the northern areas, especially Lombardia, experienced a rapid increase in deaths, while other regions like Veneto had a more gradual rise due to early testing efforts. Their analysis showed that higher movement and positivity rates were linked to more deaths, while strong primary care helped lower mortality rates. Who this helps: This helps public health officials and healthcare providers understand how to manage outbreaks more effectively.

Plain English
The study looked at how effective a compound called Morelloflavone-7,4',7″,3‴,4‴-penta-O-butanoyl (BF4), derived from a plant called Garcinia brasiliensis, is at blocking certain enzymes linked to various diseases. The researchers found that BF4 was particularly good at inhibiting the PC1/3 enzyme, with an inhibition rate of 1.13 μM, making it more effective than other enzymes like Kex2 and Furin. This is important because blocking these enzymes could play a role in treating conditions related to infections, cancer, and other serious diseases. Who this helps: This benefits patients dealing with infections and diseases linked to these enzymes, as well as researchers seeking new treatments.

Plain English
This study looked at how marijuana use affects recovery after back surgery, specifically lumbar spinal fusion. It found that while marijuana users tended to be younger, their recovery outcomes—measured by disability scores and fusion rates—were similar to those who didn't use marijuana. For instance, 96% of marijuana users and 92.3% of non-users achieved a successful fusion after 12 months, and both groups experienced a similar length of hospital stay. Who this helps: This information benefits doctors and patients considering surgery for back issues.

Plain English
This study looked at how organic and inorganic substances interact when forming chabazite zeolites, a type of material used in various applications like catalysis and filtration. The researchers found that when organic compounds (TMAda) and inorganic ones (Na or K) were used together, the amount of organic substance needed could be reduced by more than ten times, while still achieving good structure and configuration of aluminum within the zeolites. This is important because it can make the manufacturing process more efficient and environmentally friendly by minimizing the use of organic materials. Who this helps: This benefits manufacturers and researchers working on cleaner and more efficient materials for industrial use.

Plain English
This study looked at certain proteins in patients with metastatic colorectal cancer (mCRC) to see if they could indicate how well patients respond to the drug bevacizumab. Researchers found that two proteins, hERG1 and HIF-2α, were linked to better outcomes: patients with hERG1 showed improved progression-free survival, regardless of their KRAS status. This information could help doctors determine which patients are more likely to benefit from bevacizumab treatment. Who this helps: This helps doctors in selecting the right treatment for patients with metastatic colorectal cancer.

Plain English
This study looked at how the antibiotic Clarithromycin affects colorectal cancer cells. Researchers found that Clarithromycin slows down the growth of these cancer cells and triggers cell death, effectively exhausting the cell's survival mechanism called autophagy. Notably, when Clarithromycin was combined with the common chemotherapy drug 5-fluorouracil, it increased the cancer-killing effects of the treatment. Who this helps: This research benefits colorectal cancer patients by suggesting a potential new treatment option.

Plain English
This study examined how a drug called clarithromycin affects a process in colorectal cancer cells known as autophagy, which is related to cell growth and survival. The researchers found that clarithromycin disrupts autophagy by influencing a specific potassium channel, leading to damage in cancer cells. This is important because it could help develop new treatments for colorectal cancer, targeting these pathways more effectively. Who this helps: Patients with colorectal cancer.

Plain English
This study looked at twenty-four new chemical compounds derived from quinoline to see how well they fight cancer and a tropical disease called leishmaniasis. Researchers found that two specific compounds, HTI 21 and HTI 22, were the most effective at killing cancer cells. These compounds work by causing cell death through a process that relies on calcium and affects cell energy production, suggesting they could be promising options for drug development. Who this helps: This research benefits cancer patients and those suffering from leishmaniasis.

Plain English
This study focused on how two specific proteins (K11.1 and NHE1) affect the internal pH levels of colorectal cancer cells when they attach to certain surfaces, like collagen. Researchers found that when these cancer cells adhered to these surfaces, their internal pH temporarily increased, peaking at 90 minutes and lasting about three hours. This change in pH was influenced by the activity of NHE1 and K11.1, both of which also affected the cancer cells’ ability to move, potentially promoting further spread of the cancer. Who this helps: This research benefits patients with colorectal cancer by identifying potential new targets for treatment that could limit cancer spread.

Plain English
This study looked at how the arrangement of aluminum in zeolite materials affects their ability to dehydrate alcohols like methanol and ethanol. Researchers found that when certain aluminum distributions are used, the process becomes easier and faster, with a significant increase in reaction rates—specifically, the turnover rates improve as more Brønsted acid sites form six-membered rings within the zeolite structure. This understanding is important because it can lead to the development of more effective catalysts for industrial processes. Who this helps: This helps chemists and engineers working on improving catalytic processes in chemical manufacturing.

Plain English
This study looked at a type of catalyst called Cu-CHA zeolites, which are used to reduce harmful nitrogen oxides in diesel engine emissions when ammonia is present. Researchers discovered that copper ions within these zeolites can change their positions in response to different conditions, which allows them to efficiently facilitate the chemical reactions needed to lower pollution levels, particularly at low temperatures. They found that optimal performance depended on copper density and zeolite composition, with the reaction rates influenced by these factors under varying conditions. Who this helps: This benefits both patients, by improving air quality and reducing pollution-related health issues, and the automotive industry, by enhancing emission control technologies.

Plain English
Researchers studied how different environments inside a special material called zeolites (which are tiny porous structures) affect reactions that convert cyclohexanone using a type of alcohol called 2-butanol. They discovered that a specific type of zeolite, known as hydrophobic Sn-Beta, makes this reaction happen 10 times faster than another type that absorbs water (hydrophilic Sn-Beta) because it promotes a more organized structure of the alcohol that helps the reaction. This finding is important because it shows that the way a solvent is structured inside these zeolites can significantly influence chemical reactions, leading to potential improvements in chemical manufacturing processes. Who this helps: This benefits chemical engineers and industries looking to enhance reaction efficiency in synthetic processes.

Plain English
This study looked at improving a type of material called zeolites, which are used as catalysts in chemical reactions. Researchers found a way to place special metal atoms (tin) in specific parts of these zeolites, resulting in better performance. For example, the new zeolite (Sn-BEC) had a higher reaction rate than a traditional version (Sn-Beta(F)), mainly because it had more active sites available for the reaction. Who this helps: This benefits chemists and industries that rely on efficient chemical processes.

Plain English
This study looked at how well a new treatment combining a special material made from platelets (PRFM) and a bone substitute (beta-tricalcium phosphate) worked for patients undergoing spinal fusion surgery. Out of 50 patients, 92.4% showed good signs of healing after one year, and there were significant reductions in back and leg pain, with a 38% drop in opioid use among patients. This research is important because it shows this new treatment can achieve similar healing results as traditional methods without the complications from harvesting bone from the body. Who this helps: Patients undergoing spinal fusion surgery.

Plain English
This study focused on how ion channels, which are important proteins in cells, influence the way cancer cells use energy. The researchers found that cancer cells often change their metabolism to produce more acid, making the inside of the cells more acidic than the outside, which helps tumors grow and spread. Specifically, they highlighted that sodium and potassium channels play key roles in this process by helping cancer cells adapt to low oxygen levels and altered energy use. Who this helps: This research benefits doctors and scientists working to develop new treatments for cancer.

Plain English
This study looked at the hERG1 potassium channel in pre-cancerous gastric lesions (called gastric dysplasia) from 83 Italian patients to see if it could predict disease progression to gastric cancer. The researchers found that hERG1 was present in about 67% of the samples and that patients with higher hERG1 levels had shorter survival rates. Specifically, patients with a high hERG1 score had a significant decrease in both progression-free survival and overall survival, which makes hERG1 a potential new marker to identify patients at greater risk for developing gastric cancer. Who this helps: This helps patients with gastric dysplasia and their doctors by providing better tools for monitoring and managing their condition.

Plain English
This study looked at how the alignment of the neck changes as people get older, analyzing data from 118 healthy individuals aged between less than 35 and over 65. It found that neck curvature increases with age—specifically, the angle from the base of the skull to the upper spine increases significantly in people aged 55 and older. Understanding these changes is important because it can help doctors better assess neck health in aging patients and address potential issues before they develop. Who this helps: This helps patients and doctors in managing neck health as people age.

Plain English
This research reviewed the causes, treatment options, and outcomes for people with cervical spinal epidural abscesses, which are serious infections that can affect the spine. They analyzed 11 studies involving these patients and found that surgery is generally safe with few complications, but there is not enough high-quality data to clearly compare surgical and non-surgical treatments. Understanding the best time to use surgery is important, as it can impact recovery for patients, but the criteria for selecting which patients benefit most from surgery are still unclear. Who this helps: Patients suffering from cervical spinal epidural abscesses.